April 2018 Newsletter

April 26, 2018:

Disruptive Technology Steals Limelight at 2018 ASCRS Meeting in Washington, DC

Dry eye also was an area of high interest, particularly a study comparing omega-3 fatty acids with olive oil.

April 26, 2018:

AIOC Presenters Say SICS Procedure Is Best Suited to Meet India’s Cataract Needs

The country plans to increase surgical volume by 80 percent.

April 26, 2018:

Two-Thirds of Cataract Procedures Involve Anesthesiologist or Nurse Anesthetist

CMS data indicate that Anthem’s denial of monitored anesthesia care would have a big impact on surgeons.

April 26, 2018:

Venezuela’s Cataract Surgery Volume Drops in Q4-2017 to 900 Procedures

The South American country’s economic crisis forces one surgeon to plan to leave.

April 26, 2018:

Shire Accepts Takeda’s $64 Billion Preliminary Acquisition Bid

Regulators set a May 8 deadline for Takeda to make a firm offer.

April 26, 2018:

pSivida Acquires Icon Bioscience, Rebrands as EyePoint Pharmaceuticals

The move bolster’s the firm’s position in sustained-release technology.

April 26, 2018:

SightLife Surgical Rebrands as CorneaGen, Offers New Products

The company said the name change reflects its broader product offering.

April 26, 2018:

Akorn Sues Fresenius Kabi for Terminating $4.3 Billion Merger Agreement

The failed merger comes after a downturn in revenues for Akorn.

April 26, 2018:

India Issues Protectionist Rules for Medical Devices

The new standards classify medical devices into four categories, each with its own local content requirement.

April 26, 2018:

Indian IOL Pioneer Looks for New Markets to Conquer

Freedom Ophthalmic is building a new factory to expand into pharmaceuticals.

April 26, 2018:

Surgeon Implants 60-Diopter IOL Made by Freedom Ophthalmic

Severely hyperopic patient had a shallow chamber and high intraocular pressure from angle-closure glaucoma.

April 26, 2018:

Omidria Earns Listing on VA Formulary, Regains CMS Pass-Through Status

The drug’s pass-through status expired Dec. 31. It restarts Oct. 1, 2018.

April 26, 2018:

US FDA Grants De Novo Request for IDx-DR’s AI Diagnostic System for Diabetic Retinopathy

The device is designed to provide a screening test during a routine office visit in a primary care setting.

April 26, 2018:

OIS@ASCRS Draws 550 attendees; Companies Outline Product Timelines

Aerie announced that it planned to launch Rhopressa for glaucoma in May, while Kala reported positive Phase III results for its dry eye candidate, KPI-121.

April 26, 2018:

Market Report: Ophthalmic Diagnostic Equipment Market to Generate $3.3 Billion in 2018

The segment is expected to grow at rate of 4 percent through 2023.

April 26, 2018:

Market Report: China’s Ophthalmic Market Expected to Grow at 11.3 Percent through 2023

Factors driving growth include more government and private spending and an expanding elderly population.

April 26, 2018:

Glaukos Files Patent Infringement Suit Against Ivantis over Glaucoma Technology

The suit alleges that the Hydrus Microstent infringes two Glaukos patents that protect a method of treating glaucoma using Schlemm’s canal.

April 26, 2018:

US Appeals Court Postpones Mylan Challenge to Restasis Patents, Plans Hearing on Tribal Deal

The US patent board had planned to render a final decision on the patentability of the challenged patents by June 6.

April 26, 2018:

Regeneron Links Syringes to Spike in Cases of Inflammation after Eylea Injections

The company recommended that doctors not use Eylea kits with certain lot numbers.

April 26, 2018:

Ivantis: Hydrus Outperforms Two Glaukos iStents in COMPARE Trial

The study used a stand-alone procedure to avoid the confounding effect of cataract surgery.

April 26, 2018:

Market Scope Weekly Polls

April 26, 2018:

Ionis Signs $1 Billion Collaboration Extension with Biogen; Other Firms Raise $93 Million

April 26, 2018:

April 2018 News Briefs

Social media